Healthcare
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Trend Stats
1-Month Return
+7.36%
3-Month Return
+8.74%
12-Month Return
+24.32%
Volatility Score
1.8
RSI
58.5
ST Trend
Up
LT Trend
Up
Short-Term Trend
Up
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Healthcare
S&P 500 Index
Components
| Symbol | Company | Market Cap | 12 mo return Performance over the past 12 months | 3 mo return Performance over the past 3 months | 1 mo return Performance over the past month | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co | $1T | +53.87% | +27.41% | +6.04% | 3.3 | Up | Up |
| JNJ | Johnson&Johnson | $602B | +58.44% | +8.68% | +8.04% | 2.6 | Up | Up |
| ABBV | AbbVie | $449B | +38.64% | +23.00% | +15.85% | 2.8 | Up | Up |
| UNH | Unitedhealth Gro | $384B | +54.79% | +32.00% | +6.65% | 2.8 | Up | Up |
| MRK | Merck | $315B | +64.79% | +7.85% | +10.45% | 2.9 | Up | Up |
| TMO | Thermo Fisher Sc | $202B | +28.85% | +1.22% | +15.33% | 2.6 | Up | Neutral |
| AMGN | Amgen | $201B | +28.00% | +3.87% | +7.21% | 2.4 | Up | Up |
| ABT | Abbott Laborator | $172B | -16.71% | +4.74% | +14.57% | 3.1 | Up | Down |
| GILD | Gilead Sciences | $169B | +27.31% | -1.80% | +7.04% | 2.9 | Up | Up |
| DHR | Danaher | $145B | +8.04% | +4.88% | +14.90% | 2.6 | Up | Neutral |
| PFE | Pfizer | $143B | +9.52% | -7.61% | -3.36% | 2.3 | Down | Down |
| ISRG | Intuitive Surgic | $142B | -33.40% | -26.38% | -14.11% | 4.6 | Down | Down |
| CVS | CVS Health | $136B | +79.79% | +40.25% | +8.38% | 2.4 | Up | Up |
| SYK | Stryker | $127B | -17.02% | -6.58% | +6.50% | 3.5 | Up | Down |
| BMY | Bristol-MyersSqu | $124B | +34.41% | +2.09% | +11.12% | 2.6 | Up | Up |
| VRTX | Vertex Pharma | $123B | +5.62% | +10.07% | +5.81% | 3.2 | Up | Up |
| MDT | Medtronic | $107B | -4.13% | -2.60% | +7.44% | 2.9 | Up | Down |
| MCK | Mckesson | $98B | +19.02% | -2.78% | +7.90% | 2.7 | Up | Neutral |
| HCA | HCA Healthcare | $86B | +3.48% | -23.79% | -4.37% | 3.7 | Down | Down |
| ELV | Elevance Health | $81B | +37.48% | +15.97% | -4.64% | 3.7 | Down | Up |
| CI | The Cigna | $75B | -2.71% | +1.59% | -1.28% | 3.0 | Down | Neutral |
| REGN | Regeneron Pharma | $71B | +25.41% | -9.71% | +11.31% | 2.4 | Up | Down |
| BSX | Boston Scientifi | $66B | -57.52% | -31.45% | -2.05% | 3.5 | Down | Down |
| COR | Cencora | $60B | +5.93% | -5.79% | +11.12% | 2.6 | Up | Down |
| CAH | Cardinal Health | $54B | +44.71% | +7.02% | +1.21% | 2.5 | Up | Up |
| EW | Edwards Lifescns | $51B | +12.08% | +5.85% | -1.10% | 2.9 | Down | Neutral |
| HUM | Humana | $46B | +84.10% | +95.45% | +10.76% | 3.8 | Up | Up |
| IDXX | IDEXX Labs | $45B | +10.27% | -3.70% | +3.91% | 3.5 | Neutral | Down |
| BDX | Becton Dickinson | $44B | -9.39% | +0.47% | +11.69% | 2.9 | Up | Down |
| A | Agilent Tech | $38B | +16.25% | +8.08% | +5.94% | 2.9 | Up | Neutral |
| WAT | Waters | $37B | +28.33% | +12.57% | +3.36% | 2.8 | Neutral | Up |
| IQV | IQVIA Holdings | $35B | +28.41% | +16.89% | +20.85% | 3.4 | Up | Up |
| ZTS | Zoetis-A | $32B | -47.85% | -37.17% | -0.91% | 3.2 | Down | Down |
| VEEV | Veeva Systems-A | $32B | -30.79% | +16.33% | +26.17% | 3.7 | Up | Down |
| CNC | Centene | $32B | +137.71% | +74.06% | +9.56% | 3.6 | Up | Up |
| BIIB | Biogen | $31B | +64.81% | +16.15% | +3.68% | 4.3 | Up | Up |
| DXCM | Dexcom | $30B | -8.63% | +19.80% | +7.61% | 3.5 | Up | Up |
| GEHC | GE Hltc Tech | $30B | -16.82% | -15.52% | +3.14% | 3.3 | Down | Down |
| RMD | Resmed | $29B | -22.09% | -12.51% | +6.82% | 3.5 | Down | Down |
| MTD | Mettler Toledo I | $27B | +9.64% | -2.28% | +15.98% | 2.6 | Up | Down |
| 0 | 0 | 0 | 0 | Bullish | Bullish |